Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease

Progress in Biophysics and Molecular Biology

Volumn 118, Issue 1-2, 2015, Pages 8-13

  Treviño, Lindsey S ^a   Wang, Quan ^a   Walker, Cheryl L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cancer; Developmental reprogramming; Histone modifiers; Phosphorylation

Indexed keywords

CARCINOGEN;

ANIMAL; DISEASES; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEALTH; HUMAN; PHOSPHORYLATION;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; DISEASE; EPIGENESIS, GENETIC; GROWTH AND DEVELOPMENT; HEALTH; HUMANS; PHOSPHORYLATION;

EID: 84930539268     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2015.02.013     Document Type: Review

References (40)

1. Arteaga M.F., Mikesch J.H., Qiu J., Christensen J., Helin K., Kogan S.C., Dong S., So C.W. The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell. 2013, 23:376-389.
2. Ayoub N., Jeyasekharan A.D., Bernal J.A., Venkitaraman A.R. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 2008, 453:682-686.
3. Baba A., Ohtake F., Okuno Y., Yokota K., Okada M., Imai Y., Ni M., Meyer C.A., Igarashi K., Kanno J., Brown M., Kato S. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat. Cell. Biol. 2011, 13:668-675.
4. Barker D.J. The origins of the developmental origins theory. J.Intern Med. 2007, 261:412-417.
5. Barker D.J. Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health 2012, 126:185-189.
6. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002, 3:39-44.
7. Boeke J., Regnard C., Cai W., Johansen J., Johansen K.M., Becker P.B., Imhof A. Phosphorylation of SU(VAR)3-9 by the chromosomal kinase JIL-1. PLoS One 2010, 5:e10042.
8. Bradley C., van der Meer R., Roodi N., Yan H., Chandrasekharan M.B., Sun Z.W., Mernaugh R.L., Parl F.F. Carcinogen-induced histone alteration in normal human mammary epithelial cells. Carcinogenesis 2007, 28:2184-2192.
9. Bredfeldt T.G., Greathouse K.L., Safe S.H., Hung M.C., Bedford M.T., Walker C.L. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol. Endocrinol. 2010, 24:993-1006.
10. Cha T.L., Zhou B.P., Xia W., Wu Y., Yang C.C., Chen C.T., Ping B., Otte A.P., Hung M.C. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 2005, 310:306-310.
11. Chen D., Huang S.M., Stallcup M.R. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J.Biol. Chem. 2000, 275:40810-40816.
12. Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A., Simon J.A., Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell. Biol. 2010, 12:1108-1114.
13. Cheng T.F., Choudhuri S., Muldoon-Jacobs K. Epigenetic targets of some toxicologically relevant metals: a review of the literature. J.Appl. Toxicol. 2012, 32:643-653.
14. Cook J.D., Davis B.J., Cai S.L., Barrett J.C., Conti C.J., Walker C.L. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8644-8649.
15. Decarlo D., Hadden M.K. Oncoepigenomics: making histone lysine methylation count. Eur. J. Med. Chem. 2012, 56:179-194.
16. Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett. 2011, 585:2024-2031.
17. Doherty L.F., Bromer J.G., Zhou Y., Aldad T.S., Taylor H.S. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm. Cancer 2010, 1:146-155.
18. Feng Q., He B., Jung S.Y., Song Y., Qin J., Tsai S.Y., Tsai M.J., O'Malley B.W. Biochemical control of CARM1 enzymatic activity by phosphorylation. J.Biol. Chem. 2009, 284:36167-36174.
19. Greathouse K.L., Bredfeldt T., Everitt J.I., Lin K., Berry T., Kannan K., Mittelstadt M.L., Ho S.M., Walker C.L. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol. Cancer Res. 2012, 10:546-557.
20. Hanson M.A., Gluckman P.D. Developmental origins of health and disease - global public health implications. Best. Pract. Res. Clin. Obstet. Gynaecol. 2015 Jan, 29(1):24-31.
21. Higashimoto K., Kuhn P., Desai D., Cheng X., Xu W. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12318-12323.
22. Hussain M., Rao M., Humphries A.E., Hong J.A., Liu F., Yang M., Caragacianu D., Schrump D.S. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res. 2009, 69:3570-3578.
23. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
24. Kaneko S., Li G., Son J., Xu C.F., Margueron R., Neubert T.A., Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes. Dev. 2010, 24:2615-2620.
25. Liang C.Y., Hsu P.H., Chou D.F., Pan C.Y., Wang L.C., Huang W.C., Tsai M.D., Lo W.S. The histone H3K36 demethylase Rph1/KDM4 regulates the expression of the photoreactivation gene PHR1. Nucleic Acids Res. 2011, 39:4151-4165.
26. Liu F., Zhao X., Perna F., Wang L., Koppikar P., Abdel-Wahab O., Harr M.W., Levine R.L., Xu H., Tefferi A., Deblasio A., Hatlen M., Menendez S., Nimer S.D. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell. 2011, 19:283-294.
27. Liu H., Takeda S., Kumar R., Westergard T.D., Brown E.J., Pandita T.K., Cheng E.H., Hsieh J.J. Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature 2010, 467:343-346.
28. Liu W., Tanasa B., Tyurina O.V., Zhou T.Y., Gassmann R., Liu W.T., Ohgi K.A., Benner C., Garcia-Bassets I., Aggarwal A.K., Desai A., Dorrestein P.C., Glass C.K., Rosenfeld M.G. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 2010, 466:508-512.
29. Lomberk G., Bensi D., Fernandez-Zapico M.E., Urrutia R. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat. Cell. Biol. 2006, 8:407-415.
30. Park S.H., Yu S.E., Chai Y.G., Jang Y.K. CDK2-dependent phosphorylation of Suv39H1 is involved in control of heterochromatin replication during cell cycle progression. Nucleic Acids Res. 2014, 42:6196-6207.
31. Sadikovic B., Andrews J., Carter D., Robinson J., Rodenhiser D.I. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J.Biol. Chem. 2008, 283:4051-4060.
32. Sampath S.C., Marazzi I., Yap K.L., Sampath S.C., Krutchinsky A.N., Mecklenbrauker I., Viale A., Rudensky E., Zhou M.M., Chait B.T., Tarakhovsky A. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol. Cell. 2007, 27:596-608.
33. Smith E., Lin C., Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes. Dev. 2011, 25:661-672.
34. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M.Y., Takeyama K., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S. Ahistone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell. Biol. 2007, 9:1273-1285.
35. Toffolo E., Rusconi F., Paganini L., Tortorici M., Pilotto S., Heise C., Verpelli C., Tedeschi G., Maffioli E., Sala C., Mattevi A., Battaglioli E. Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2. J.Neurochem. 2014, 128:603-616.
36. Walker C.L., Ho S.M. Developmental reprogramming of cancer susceptibility. Nat. Rev. Cancer 2012, 12:479-486.
37. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., Cui K., Roh T.Y., Peng W., Zhang M.Q., Zhao K. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 2008, 40:897-903.
38. Wei Y., Chen Y.H., Li L.Y., Lang J., Yeh S.P., Shi B., Yang C.C., Yang J.Y., Lin C.Y., Lai C.C., Hung M.C. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat. Cell. Biol. 2011, 13:87-94.
39. Wu S., Wang W., Kong X., Congdon L.M., Yokomori K., Kirschner M.W., Rice J.C. Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression. Genes. Dev. 2010, 24:2531-2542.
40. Zhao C., Nguyen T., Yusifov T., Glasgow B.J., Lehrer R.I. Lipophilins: human peptides homologous to rat prostatein. Biochem. Biophys. Res. Commun. 1999, 256:147-155.